Latest News

HCA Healthcare delivered a strong first quarter, beating expectations in both earnings and revenue.

A credit card issuer might not seem like a recession-resistant business, but you might be surprised.

Comparing yourself to a broad average isn't always helpful, but it can give you some degree of perspective.

Pharmaceutical company AbbVie (NYSE:ABBV) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.4% year on year to $13.34 billion. Its non-GAAP profit of $2.46 per share was 2.6% above analysts’ consensus estimates.

Investors are heavily discounting Alphabet's future. This may present an opportunity.

Will lower interest rates once again lead to higher crypto prices?

According to the Education Data Initiative report, the total outstanding debt in US student loans (federal and private) is a record $1.77 trillion for more than 42 million borrowers.

COSTAR GROUP INC (NASDAQ:CSGP) Reveals Intriguing Technical Aspects. Indications Suggest NASDAQ:CSGP Could Be on the Verge of a Breakout. Here's What You Need to Know.

Trump's attacks on Harvard and deportation threats against foreign students is sparking global distrust in U.S. education.

The company also raised its outlook for 2025, though noted that guidance hike doesn't include potential pharma sector tariffs.

AUD/USD falls to near 0.6380 due to a recovery move in the US Dollar.

Hospital operator HCA Healthcare (NYSE:HCA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 5.7% year on year to $18.32 billion. The company expects the full year’s revenue to be around $74.3 billion, close to analysts’ estimates. Its GAAP profit of $6.45 per share was 11.5% above analysts’ consensus estimates.

The company is eyeing FDA approval for its drug, lenacapavir, for HIV prevention by mid-June.

The stock is progressing through minute wave {i} within minor wave 5, indicating strength in the ongoing bullish momentum.

TOLL BROTHERS INC is a hidden gem, featuring undervaluation and robust fundamentals. NYSE:TOL showcases decent financial health and profitability, coupled with an attractive price.

Freight transportation and logistics provider Saia (NASDAQ:SAIA) fell short of the market’s revenue expectations in Q1 CY2025 as sales rose 4.3% year on year to $787.6 million. Its GAAP profit of $1.86 per share was 32.6% below analysts’ consensus estimates.